Aquinox Prices Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Canaccord Genuity Raises Price Target on Aquinox Pharma (AQXP) to $22 on Supporting Evidence for AQX-1125
September 11, 2015 9:24 AM EDTCanaccord Genuity reiterated a Buy rating on Aquinox Pharmaceutical (NASDAQ: AQXP), and raised the price target to $22.00 (from $10.00), on supporting evidence for AQX-1125, and ahead of FDA meetings. Aquinox will meet with FDA, on BPS/IC, for an end of P2 meeting in Nov. to finalize two Ph3's, the 1st of which should start by mid-2016.
Analyst... More
Aquinox Pharma (AQXP) 5.5M Offering Common Stock Prices at $15.50/Share
September 10, 2015 9:15 AM EDTAquinox Pharma (NASDAQ: AQXP) announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $15.50 per share. In addition, Aquinox has granted the underwriters a 30-day option to purchase up to 825,000 additional... More
